Highly sensitive real-time PCR for the detection of EGFR mutations in lung adenocarcinoma. Is it worth it?

Rodon Natalia1, Roman Ruth1, Verdu Montse1,3, Garcia Beatriz1, Pujol Merce1 and Puig Xavier1,2,3.

1BIOPAT.Biopatologia Molecular, SL, Grup Assistencia, Barcelona, Spain; 2Hospital de Barcelona, SCIAS, Grup Assistencia, Barcelona, Spain; 3Histopat Laboratoris, Barcelona, Spain.

Background: Mutations involving the epidermal growth factor receptor (EGFR) correlate with responsiveness to tyrosine kinase inhibitors (TKIs), which significantly improves patient survival in lung adenocarcinoma (AC). These mutations are described […]


Genetic alterations of the epidermal growth factor receptor pathway in a series of non-small cell lung cancer characterized by morphology and immunophenotype

Verdú M,1 Colomer A,1 Erill N,1 Roman R,2 Górriz M, 1,2 Ibáñez R,1 Cordon-Cardo C,1 Puig X.1,2

1HISTOPAT Laboratoris, Barcelona, Catalonia, Spain & 2BIOPAT. Biopatologia Molecular, Grup Assistència.

Background: Non-small cell lung cancer (NSCLC) is classified in two main categories: adenocarcinoma (AC), which includes bronchioloalveolar carcinoma (BAC), and squamous cell carcinoma (SCC). Activating mutations and increased copy […]


Epidermal growth factor receptor in non small cell lung cancer: Gene copy number and mutational study

Colomer A1, Erill N1, Verdú M2, Román R 1, Górriz M2, Ibáñez R1, Menoyo A1, Cordon-Cardo C3, Puig X 1,2.

1BIOPAT, Grup Assistència, 2HISTOPAT Laboratoris, Barcelona, Spain; and 3Division of Molecular Pathology, Memorial Sloan-Kettering Cancer Center, New York, United States.

Background: Activating mutations of the EGFR gene were identified in tumors from patients with non small cell […]


Carcinoma de pulmón de células no pequeñas: caracterización inmunohistoquímica y estudio molecular del gen del receptor de EGF

N Erill1, A Colomer1, M Verdú2, R Román1, A Menoyo1, Carlos Cordón-Cardó1,2,3, Xavier Puig1,2.

1 BIOPAT. Biopatologia Molecular.  Grup Assistència. Barcelona. 2 Histopat laboratoris, Barcelona. 3 Division of Molecular Pathology, Memorial Sloan-Kettering Cancer Center, New York. 

Texto completo

Póster presentado en:

XXII Congreso de la Sociedad Española de Anatomía Patológica 2005


Diagnostic sub-classification of non-small cell lung cancer: Importance in clinical therapeutics and prognostication

M. J. Donovan, A. Kotsianti, A. Colomer, M. Verdú, M. Clayton, H. Pang, S. Hamann, C. Cordón-Cardó, X. Puig.

Background: The association of EGFR mutations with bronchoalveolar carcinoma (BAC) / non-small cell lung cancer (NSCLC) and the therapeutic and prognostic variability reported for lung cancer has reinforced the need for more accurate NSCLC sub-classification. The present […]